You searched for metabolic diseases

News and Trends 16 Dec 2022

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

…in these important areas of unmet need.” Ruth Gimeno, group vice president, diabetes and metabolic research, Lilly said: “Continued innovation across diabetes and metabolic diseases has been a key priority…

December 16, 2022 - 2 minutesmins - By Jim Cornall

affiris peptide vaccine affitope cholesterol

News and Trends 29 Jun 2016

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

…cardiometabolic and neurodegenerative diseases as more candidates break into clinical development. Based at the Campus Vienna Biocenter (Austria), AFFiRiS is developing immunotherapies to prevent chronic diseases. Some of its targets…

June 29, 2016 - 2 minutesmins - By Denise Neves Gameiro

lysosomal storage disorders azafaros rare disease

News and Trends 10 Feb 2020

First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M

…part of the money to fund the development of small molecule treatments for rare diseases, including its lead candidate aimed to treat lysosomal storage disorders. The rest of the money…

February 10, 2020 - 2 minutesmins - By Jonathan Smith

Biotech deals partnerships and MA tracker

2024 biotech deals tracker: the latest partnerships and M&A

…have not been disclosed. September 2024: HAYA Therapeutics, based in Switzerland, has partnered with Lilly, based in the United States, to discover genome targets for metabolic diseases. HAYA is set…

March 7, 2024 - 1 minutemin - By Aurore Michelin

Best in Biotech 5 Mar 2024

Fourteen biotech companies with market caps exceeding $100 billion

…conditions including immune diseases, cancer, neurological disorders, infectious diseases, cardiovascular, and metabolic diseases. Its consumer products span oral care, baby care, beauty, over-the-counter medicines, women’s health, and wound care categories….

March 5, 2024 - 18 minutesmins - By Jules Adam

News and Trends 14 Sep 2022

NTU Singapore opens microbiome research center to study obesity and chronic diseases

…microbes causes the body to be more susceptible to disorders such as obesity, metabolic diseases, cancers, lung, and skin diseases. The new research centre is led by programme director, Sunny…

September 14, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 28 Feb 2018

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

…candidate, MIN-102, for X-linked Adrenoleukodystrophy, spun out Gain Therapeutics last week. This new biotech will use a platform called SEE-Tx to develop pharmacological chaperones for rare metabolic diseases. These small…

February 28, 2018 - 8 minutesmins - By Alex Dale

2024 biotech funding tracker: recent highlights

…and B | cardiometabolic disease therapies | phase 2 in cardiovascular diseases Santa Ana Bio (USA): $168 million series A and B | precision medicine | IND-enabling stage in urticaria,…

February 23, 2024 - 1 minutemin - By Aurore Michelin

In Depth 19 Jun 2024

MASH candidates make a splash after first drug approval

…showing promising results. So, this is a really good time for MASH therapeutics.” New treatments related to metabolic diseases ⁠⁠Indacaterol for the Treatment Obesity and Related Metabolic Diseases – Texas…

June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 22 Sep 2022

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

…development of HU6 and a pipeline of controlled metabolic accelerators to address a range of cardio-metabolic conditions.” About Rivus Pharmaceuticals’ CMAs Nearly half of American adults are living with cardio-metabolic…

September 22, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…involvement in various diseases – alterations in miRNA expression profiles have been linked to cancer, cardiovascular diseases, and neurodegenerative disorders. This connection positions miRNAs as both potential biomarkers for disease…

November 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 4 Nov 2024

Top biotech deals of October 2024

…in metabolic diseases continue As always, interest in targeting metabolic diseases remains strong. And once again, Lilly is in the game. It has partnered with insitro, a California-based drug company,…

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M

2024 biotech deals tracker: the latest partnerships and M&A

Fourteen biotech companies with market caps exceeding $100 billion

NTU Singapore opens microbiome research center to study obesity and chronic diseases

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

2024 biotech funding tracker: recent highlights

MASH candidates make a splash after first drug approval

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

Seven miRNA-focused companies pioneering new therapies in 2024

Top biotech deals of October 2024

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!